YTS104

· Institute of Hematology & Blood Diseases Hospital, China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YTS104, covering 2025-08-15 to 2025-08-15. Get the full timeline:

Most recent: Clinical Trial Update: YTS104 Cell Injection for the Treatment of Relapsed or Refractory Multiple Myeloma [Phase 1]